Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$4.08M
105.75K shares
REED ELIZABETH E plans to sell 105.75K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $4.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Performance Shares
Not Applicable
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Performance Shares Not Applicable | 2.08K | — |
| Total | 2.08K | ||
Completed
Units to sell
2.17K
Market value
$101.4K
Units to sell
20K
Market value
$900.0K
Units to sell
6.79K
Market value
$283.8K
Units to sell
7.21K
Market value
$302.5K
Units to sell
37.50K
Market value
$1.54M
Units to sell
10K
Market value
$300.0K
Units to sell
10K
Market value
$280.9K
Units to sell
10K
Market value
$278.3K
Planned — Approximate Date
Units to sell
2.08K
Market value
$91.2K
Units
105.75K
Value
$4.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/5/2026 | 2.17K | $101.4K | — | Completed |
5/4/2026 | 20K | $900.0K | — | Completed |
4/15/2026 | 6.79K | $283.8K | — | Completed |
4/14/2026 | 7.21K | $302.5K | — | Completed |
4/14/2026 | 37.50K | $1.54M | — | Completed |
4/1/2026 | 10K | $300.0K | — | Completed |
3/16/2026 | 10K | $280.9K | — | Completed |
2/17/2026 | 10K | $278.3K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 2.08K | $91.2K | NASDAQ | Planned |
| Total | 105.75K | $4.08M | ||